Health Care

Pfizer inc (NYSE:PFE) Q1 2023 Earnings Call dated May. 02, 2023.   Corporate Participants: Christopher Stevo -- Senior Vice President, Investor Relations…

Corcept Therapeutics Incorporated (NASDAQ: CORT) Q1 2023 Earnings Call dated May. 03, 2023 Corporate participants: Atabak Mokari -- Chief Financial…

Sage Therapeutics Inc (NASDAQ:SAGE) Q1 2023 Earnings Call dated May. 02, 2023. Corporate Participants: Helen Rubinstein -- Director of Investor Relations Barry…

10X Genomics Inc (NASDAQ: TXG) Q1 2023 Earnings Call dated May. 03, 2023 Corporate participants: Cassie Corneau -- Head, Investor…

CVS Health Corporation (NYSE: CVS) Q1 2023 Earnings Call dated May. 03, 2023 Corporate participants: Larry McGrath -- Senior Vice-President…

Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday despite the company delivering better-than-expected results for the first quarter…

Pharmaceutical solutions provider AmerisourceBergen Corporation (NYSE: ABC) reported higher revenues and adjusted earnings for the second quarter of 2023. Second-quarter…

Pfizer Inc. (NYSE: PFE) reported first quarter 2023 earnings results today. Revenues declined 29% year-over-year to $18.3 billion. Reported net…

Medical technology company Stryker Corporation (NYSE: SYK) announced operating results for the first quarter of 2023, reporting higher sales and…

Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported a decline in adjusted earnings for the first quarter, despite an…

Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that operates as an integrated drug procurement and delivery platform.…

ImmunoGen Inc (NASDAQ:IMGN) Q1 2023 Earnings Call dated Apr. 28, 2023. Corporate Participants: Anabel Chan -- Head, Investor Relations Mark Enyedy -- President &…

IQVIA Holdings Inc (NYSE: IQV) Q1 2023 Earnings Conference Call  dated Apr. 27, 2023 Corporate Participants: Nick Childs -- Senior…

Amgen Inc. (NASDAQ: AMGN) has reported lower revenues and adjusted earnings for the first quarter of 2023. The biotechnology firm…

Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.4 billion for the first quarter of 2023, which was down…

Eli Lilly and Company (NYSE: LLY) Q1 2023 earnings call dated Apr. 27, 2023 Corporate Participants: Joe Fletcher -- Senior Vice President…

Biotechnology company Bristol Myers Squibb (NYSE: BMY) said its first-quarter adjusted earnings increased modestly, despite a decline in revenues. Net…

Pharma firm Merck & Co., Inc.  (NYSE: MRK) on Thursday reported lower earnings for the first quarter of 2023, due to…

Eli Lilly and Company (NYSE: LLY) on Thursday reported lower earnings and revenues for the first quarter of 2023. The…

Amgen Inc.  (NASDAQ: AMGN) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Arvind Sood — Vice President, Investor Relations Robert…

Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said its scientific co-founder Jack Elias published new findings in Cancer Research,…